Europe Pharmaceutical Excipients Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Organic Chemicals, Inorganic Chemicals, and Other Products); Functionality (Fillers and Diluents, Suspending and Viscosity Agents, Coating Agents, Binders, Preservatives, Emulsifying Agents, and Other Functionalities); Type of Formulation (Oral Formulations, Topical Formulations, Parenteral Formulations, and Other Formulations)

No. of Pages: 167    |    Report Code: TIPRE00022813    |    Category: Chemicals and Materials

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Pharmaceutical Excipients Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Pharmaceutical Excipients Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Pharmaceutical Excipients Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing demand for drug formulations
  • 5.1.2 Rise in biologic and generic drugs
5.2 Market Opportunities
  • 5.2.1 Expansion in pharmaceutical excipients market
  • 5.2.2 Growth in oral solid dosage forms
5.3 Future Trends
  • 5.3.1 Growth in biopharmaceutical excipients
  • 5.3.2 Increasing demand for customized drug delivery systems
5.4 Impact of Drivers and Restraints

6. Europe Pharmaceutical Excipients Market Regional Analysis

6.1 Europe Pharmaceutical Excipients Market Overview
6.2 Europe Pharmaceutical Excipients Market Revenue 2020-2028 (US$ Million)
6.3 Europe Pharmaceutical Excipients Market Forecast Analysis

7. Europe Pharmaceutical Excipients Market Analysis – by Product

7.1 Organic Chemicals
  • 7.1.1 Overview
  • 7.1.2 Organic Chemicals: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Inorganic Chemicals
  • 7.2.1 Overview
  • 7.2.2 Inorganic Chemicals: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Other Products
  • 7.3.1 Overview
  • 7.3.2 Other Products: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Pharmaceutical Excipients Market Analysis – by Functionality

8.1 Fillers and Diluents
  • 8.1.1 Overview
  • 8.1.2 Fillers and Diluents: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Suspending and Viscosity Agents
  • 8.2.1 Overview
  • 8.2.2 Suspending and Viscosity Agents: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Coating Agents
  • 8.3.1 Overview
  • 8.3.2 Coating Agents: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Binders
  • 8.4.1 Overview
  • 8.4.2 Binders: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Preservatives
  • 8.5.1 Overview
  • 8.5.2 Preservatives: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Emulsifying Agents
  • 8.6.1 Overview
  • 8.6.2 Emulsifying Agents: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Functionalities
  • 8.7.1 Overview
  • 8.7.2 Other Functionalities: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Pharmaceutical Excipients Market Analysis – by Type of Formulation

9.1 Oral Formulations
  • 9.1.1 Overview
  • 9.1.2 Other Functionalities: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Topical Formulations
  • 9.2.1 Overview
  • 9.2.2 Other Functionalities: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Parenteral Formulations
  • 9.3.1 Overview
  • 9.3.2 Other Functionalities: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Other Formulations
  • 9.4.1 Overview
  • 9.4.2 Other Functionalities: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Pharmaceutical Excipients Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Pharmaceutical Excipients Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Europe Pharmaceutical Excipients Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 UK: Europe Pharmaceutical Excipients Market Breakdown, by Product
    • 10.1.1.1.2 UK: Europe Pharmaceutical Excipients Market Breakdown, by Functionality
    • 10.1.1.1.3 UK: Europe Pharmaceutical Excipients Market Breakdown, by Type of Formulation
  • 10.1.1.2 Germany: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Pharmaceutical Excipients Market Breakdown, by Product
    • 10.1.1.2.2 Germany: Europe Pharmaceutical Excipients Market Breakdown, by Functionality
    • 10.1.1.2.3 Germany: Europe Pharmaceutical Excipients Market Breakdown, by Type of Formulation
  • 10.1.1.3 France: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 France: Europe Pharmaceutical Excipients Market Breakdown, by Product
    • 10.1.1.3.2 France: Europe Pharmaceutical Excipients Market Breakdown, by Functionality
    • 10.1.1.3.3 France: Europe Pharmaceutical Excipients Market Breakdown, by Type of Formulation
  • 10.1.1.4 Russia: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Pharmaceutical Excipients Market Breakdown, by Product
    • 10.1.1.4.2 Russia: Europe Pharmaceutical Excipients Market Breakdown, by Functionality
    • 10.1.1.4.3 Russia: Europe Pharmaceutical Excipients Market Breakdown, by Type of Formulation
  • 10.1.1.5 Italy: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Pharmaceutical Excipients Market Breakdown, by Product
    • 10.1.1.5.2 Italy: Europe Pharmaceutical Excipients Market Breakdown, by Functionality
    • 10.1.1.5.3 Italy: Europe Pharmaceutical Excipients Market Breakdown, by Type of Formulation
  • 10.1.1.6 Rest of Europe: Europe Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Pharmaceutical Excipients Market Breakdown, by Product
    • 10.1.1.6.2 Rest of Europe: Europe Pharmaceutical Excipients Market Breakdown, by Functionality
    • 10.1.1.6.3 Rest of Europe: Europe Pharmaceutical Excipients Market Breakdown, by Type of Formulation

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Pharmaceutical Excipients Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Archer-Daniels-Midland Co
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 AshLand Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Avantor Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 BASF SE
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Evonik Industries AG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 JRS PHARMA GmbH & Co. KG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 MEGGLE GmbH & Co KG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Roquette Freres SA
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 The Dow Chemical Co
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 The Lubrizol Corp
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Europe Pharmaceutical Excipients Market

  1. Archer-Daniels-Midland Co
  2. AshLand Inc
  3. Avantor Inc
  4. BASF SE
  5. Evonik Industries AG
  6. JRS PHARMA GmbH & Co. KG
  7. MEGGLE GmbH & Co KG
  8. Roquette Freres SA
  9. The Dow Chemical Co
  10. The Lubrizol Corp
europe-pharmaceutical-excipients-market